Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

The Gairdner Foundation is pleased to announce the 2025 Canada Gairdner Award laureates, recognizing some of the world's most significant biomedical and global health research and discoveries.

A 47-year-old man with cystic fibrosis hopes that stories like his will be reassuring to younger people diagnosed with the ...

EVŌQ Nano, a nanoscience company that engineers novel nanoparticles for the life, material, and textile science industries, ...

All states should adopt updated screening protocols so more newborns with cystic fibrosis can be diagnosed in the first weeks of life, when interventions can have the greatest benefit, according to ...

Canada Gairdner Awards recognize the world’s most accomplished researchers whose work is improving our understanding of human ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination ...

For almost a century Cystic Fibrosis all but guaranteed an early death. Nowadays advances in modular drug therapy have ...

The thickened secretions can block and damage secreting glands and allow infections to occur, particularly in the lungs. People with cystic fibrosis can develop endocrine, gastrointestinal ...